Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro
Authors
Keywords
Kynurenic acid, Central nervous system, Cyclooxygenase-2, Cyclooxygenase-2 inhibitors, Inflammation
Journal
NEUROTOXICITY RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-03
DOI
10.1007/s12640-018-9952-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort
- (2018) G. Fond et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- What does plasma CRP tell us about peripheral and central inflammation in depression?
- (2018) Jennifer C. Felger et al. MOLECULAR PSYCHIATRY
- Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: Relevance for schizophrenia
- (2018) Maximilian Tufvesson-Alm et al. NEUROPHARMACOLOGY
- Celecoxib Prevents Cognitive Impairment and Neuroinflammation in Soluble Amyloid β-treated Rats
- (2018) Emanuela Mhillaj et al. NEUROSCIENCE
- Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations
- (2018) Norbert Müller SCHIZOPHRENIA BULLETIN
- Effect of parecoxib sodium pretreatment combined with dexmedetomidine on early postoperative cognitive dysfunction in elderly patients after shoulder arthroscopy: A randomized double blinded controlled trial
- (2017) Jian Lu et al. JOURNAL OF CLINICAL ANESTHESIA
- Celecoxib Alleviates Memory Deficits by Downregulation of COX-2 Expression and Upregulation of the BDNF-TrkB Signaling Pathway in a Diabetic Rat Model
- (2017) Ying Yang et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials
- (2017) Wei Zheng et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex
- (2017) D.M. Bortz et al. NEUROPHARMACOLOGY
- NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update
- (2017) Daniela Cadinu et al. NEUROPHARMACOLOGY
- The kynurenine pathway in schizophrenia and bipolar disorder
- (2017) Sophie Erhardt et al. NEUROPHARMACOLOGY
- Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications
- (2017) Izabela Zakrocka et al. NEUROTOXICITY RESEARCH
- CAUSES OF MORTALITY IN SCHIZOPHRENIA: AN UPDATED REVIEW OF EUROPEAN STUDIES
- (2017) Patryk Piotrowski et al. Psychiatria Danubina
- Acute Kynurenine Challenge Disrupts Sleep–Wake Architecture and Impairs Contextual Memory in Adult Rats
- (2017) Ana Pocivavsek et al. SLEEP
- Chronic administration of parecoxib exerts anxiolytic-like and memory enhancing effects and modulates synaptophysin expression in mice
- (2017) Bo Wang et al. BMC Anesthesiology
- The beneficial effects of dietary restriction on learning are distinct from its effects on longevity and mediated by depletion of a neuroinhibitory metabolite
- (2017) Mihir Vohra et al. PLOS BIOLOGY
- Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies
- (2017) C F M G van Kesteren et al. Translational Psychiatry
- Acute Kynurenine Challenge Disrupts Sleep–Wake Architecture and Impairs Contextual Memory in Adult Rats
- (2017) Ana Pocivavsek et al. SLEEP
- Medication adherence in patients with schizophrenia
- (2016) Stephanie V Phan INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
- Spontaneous Glutamatergic Synaptic Activity Regulates Constitutive COX-2 Expression in Neurons
- (2016) Sandra J. Hewett et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Simultaneous determination of parecoxib sodium and its active metabolite valdecoxib in rat plasma by UPLC–MS/MS and its application to a pharmacokinetic study after intravenous and intramuscular administration
- (2016) Meina Liu et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Protective effects of parecoxib on rat primary astrocytes from oxidative stress induced by hydrogen peroxide
- (2016) Yun-zhi Ling et al. Journal of Zhejiang University-SCIENCE B
- Extended neuroleptic administration modulates NMDA-R subunit immunoexpression in the rat neocortex and diencephalon
- (2016) Marek Krzystanek et al. Pharmacological Reports
- Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric Disorders
- (2015) Kunio Yui et al. Current Neuropharmacology
- The effect of antipsychotic drugs on nonspecific inflammation markers in the first episode of schizophrenia
- (2015) Vesna Stefanovic et al. Vojnosanitetski Pregled
- The pharmacokinetics and in vitro/ex vivo cyclooxygenase selectivity of parecoxib and its active metabolite valdecoxib in cats
- (2014) T.W. Kim et al. VETERINARY JOURNAL
- The Cytokine Model of Schizophrenia: Emerging Therapeutic Strategies
- (2013) Ragy R. Girgis et al. BIOLOGICAL PSYCHIATRY
- Biorelevant solubility of poorly soluble drugs: Rivaroxaban, furosemide, papaverine and niflumic acid
- (2013) Krisztina Takács-Novák et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
- (2013) I. E. Sommer et al. SCHIZOPHRENIA BULLETIN
- Parecoxib mitigates spatial memory impairment induced by sevoflurane anesthesia in aged rats
- (2012) M. GONG et al. ACTA ANAESTHESIOLOGICA SCANDINAVICA
- Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood
- (2012) Ana Pocivavsek et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Induction of COX-2 Enzyme and Down-regulation of COX-1 Expression by Lipopolysaccharide (LPS) Control Prostaglandin E2Production in Astrocytes
- (2012) Miriam Font-Nieves et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clozapine Protects Dopaminergic Neurons from Inflammation-Induced Damage by Inhibiting Microglial Overactivation
- (2011) Xiaoming Hu et al. Journal of Neuroimmune Pharmacology
- Cortical Kynurenine Pathway Metabolism: A Novel Target for Cognitive Enhancement in Schizophrenia
- (2010) I. Wonodi et al. SCHIZOPHRENIA BULLETIN
- Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
- (2010) Norbert Müller et al. SCHIZOPHRENIA RESEARCH
- L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning
- (2009) Amy C. Chess et al. BEHAVIOURAL BRAIN RESEARCH
- Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to Natalizumab
- (2008) Maria del Pilar Martin ARCHIVES OF NEUROLOGY
- Niflumic acid renders dendritic cells tolerogenic and up-regulates inhibitory molecules ILT3 and ILT4
- (2008) Urban Švajger et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Interleukin-6 Mediates the Increase in NADPH-Oxidase in the Ketamine Model of Schizophrenia
- (2008) M. M. Behrens et al. JOURNAL OF NEUROSCIENCE
- Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice
- (2008) Haruhiko Sugino et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started